Αρχειοθήκη ιστολογίου

Δευτέρα 19 Μαρτίου 2018

{alpha}M{beta}2 Is Antiatherogenic in Female but Not Male Mice [INNATE IMMUNITY AND INFLAMMATION]

Atherosclerosis is a complex inflammatory process characterized by monocyte recruitment into the arterial wall, their differentiation into macrophages, and lipid accumulation. Because integrin αMβ2 (CD11b/CD18) mediates multiple diverse functions of leukocytes, we examined its role in atherogenesis. αM–/–/ApoE–/– and ApoE–/– mice were fed a control or high fat diet for 3 or 16 wk to induce atherogenesis. Unexpectedly, αM deficiency accelerated development of atherosclerosis in female but not in male mice. The size of aortic root lesions was 3–4.5-fold larger in female αM–/–/ApoE–/– than in ApoE–/– mice. Monocyte and macrophage content within the lesions was increased 2.5-fold in female αM–/–/ApoE–/– mice due to enhanced proliferation. αMβ2 elimination promoted gender-dependent foam cell formation due to enhanced uptake of cholesterol by αM–/–/ApoE–/– macrophages. This difference was attributed to enhanced expression of lipid uptake receptors, CD36 and scavenger receptor A1 (SR-A1), in female mice. Macrophages from female αM–/–/ApoE–/– mice showed dramatically reduced expression of FoxM1 transcription factor and estrogen receptors (ER) α and β. As their antagonists inhibited the effect of 17β-estradiol (E2), E2 decreased CD36, SR-A1, and foam cell formation in ApoE–/– macrophages in an ERα- and ERβ-dependent manner. However, female αM–/–/ApoE–/– macrophages failed to respond to E2 and maintained elevated CD36, SR-A1, and lipid accumulation. FoxM1 inhibition in ApoE–/– macrophages reduced ERs and enhanced CD36 and SR-A1 expression, whereas FoxM1 overexpression in αM–/–/ApoE–/– macrophages reversed their proatherogenic phenotype. We demonstrate a new, surprising atheroprotective role of αMβ2 in female ApoE–/– mice. αMβ2 maintains ER expression in macrophages and E2-dependent inhibition of foam cell formation.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2FNuzXk

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου